Literature DB >> 8340312

Naltrexone and fluoxetine in Prader-Willi syndrome.

E Benjamin1, T Buot-Smith.   

Abstract

The case discussed is of a 9-year-old boy with a diagnosis of Prader-Willi, compulsive eating, severe skin picking, mild mental retardation, and behavioral problems. Prehospital, hospital, and posthospital course is reviewed. An approach using fluoxetine and naltrexone shows a marked improvement in weight control, skin picking, and behavior. Obesity and self-mutilation are discussed with regard to the use of fluoxetine and naltrexone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8340312     DOI: 10.1097/00004583-199307000-00025

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  17 in total

1.  The recognition and treatment of pathological skin picking: a potential neurobiological underpinning of the efficacy of pharmacotherapy in impulse control disorders.

Authors:  David R Spiegel; Lindsey Finklea
Journal:  Psychiatry (Edgmont)       Date:  2009-02

2.  Self-injurious behavior and Prader-Willi syndrome: behavioral forms and body locations.

Authors:  F J Symons; M G Butler; M D Sanders; I D Feurer; T Thompson
Journal:  Am J Ment Retard       Date:  1999-05

Review 3.  Appetitive behavior, compulsivity, and neurochemistry in Prader-Willi syndrome.

Authors:  A Dimitropoulos; I D Feurer; E Roof; W Stone; M G Butler; J Sutcliffe; T Thompson
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2000

4.  Hyperphagia and self-mutilation in Prader-Willi syndrome: psychopharmacological issues.

Authors:  J A Yaryura-Tobias; M S Grunes; M E Bayles; F Neziroglu
Journal:  Eat Weight Disord       Date:  1998-12       Impact factor: 4.652

5.  Skin-Picking Disorder: A Guide to Diagnosis and Management.

Authors:  Mohammad Jafferany; Arsh Patel
Journal:  CNS Drugs       Date:  2019-04       Impact factor: 5.749

6.  Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects--a possible opioid involvement in severe depression?

Authors:  Shaul Schreiber; Avi Bleich; Chaim G Pick
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

Review 7.  Psychiatric disorders in Prader-Willi syndrome: epidemiology and management.

Authors:  Elisabeth Dykens; Bhavik Shah
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

8.  Clinical management of behavioral characteristics of Prader-Willi syndrome.

Authors:  Alan Y Ho; Anastasia Dimitropoulos
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

9.  Naltrexone in primary hyperphagic obesity wity hypochondriacal disorder - a clinical study.

Authors:  R S Pandey; S C Arya; D K Subbakrishna
Journal:  Indian J Psychiatry       Date:  1999-04       Impact factor: 1.759

Review 10.  Psychotropic treatments in Prader-Willi syndrome: a critical review of published literature.

Authors:  O Bonnot; D Cohen; D Thuilleaux; A Consoli; S Cabal; M Tauber
Journal:  Eur J Pediatr       Date:  2015-11-19       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.